These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7053408)

  • 1. Antipyrine kinetics in the elderly: prediction of age-related changes in benzodiazepine oxidizing capacity.
    Greenblatt DJ; Divoll M; Abernethy DR; Harmatz JS; Shader RI
    J Pharmacol Exp Ther; 1982 Jan; 220(1):120-6. PubMed ID: 7053408
    [No Abstract]   [Full Text] [Related]  

  • 2. Benzodiazepine kinetics: implications for therapeutics and pharmacogeriatrics.
    Greenblatt DJ; Divoll M; Abernethy DR; Ochs HR; Shader RI
    Drug Metab Rev; 1983; 14(2):251-92. PubMed ID: 6404617
    [No Abstract]   [Full Text] [Related]  

  • 3. Alprazolam kinetics in the elderly. Relation to antipyrine disposition.
    Greenblatt DJ; Divoll M; Abernethy DR; Moschitto LJ; Smith RB; Shader RI
    Arch Gen Psychiatry; 1983 Mar; 40(3):287-90. PubMed ID: 6131657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age, sex, and nitrazepam kinetics: relation to antipyrine disposition.
    Greenblatt DJ; Abernethy DR; Locniskar A; Ochs HR; Harmatz JS; Shader RI
    Clin Pharmacol Ther; 1985 Dec; 38(6):697-703. PubMed ID: 4064471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of age on antipyrine metabolism in patients with gastric cancer.
    Higuchi T; Nakamura T; Uchino H
    J Natl Cancer Inst; 1980 Nov; 65(5):897-900. PubMed ID: 6933259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ketoconazole does not impair antipyrine clearance in humans.
    Blyden GT; Abernethy DR; Greenblatt DJ
    Int J Clin Pharmacol Ther Toxicol; 1986 May; 24(5):225-6. PubMed ID: 3733272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antipyrine metabolism in lung cancer patients and their relatives.
    Radzikowska E; Gazdzik W; Rowińska-Zakrzewska E
    Rocz Akad Med Bialymst; 1997; 42 Suppl 1():297-308. PubMed ID: 9337547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of aging on the oxidative and conjugative metabolism of propranolol.
    Tateishi T; Fujimura A; Shiga T; Ohashi K; Ebihara A
    Int J Clin Pharmacol Res; 1995; 15(3):95-101. PubMed ID: 8847155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antipyrine metabolism in lung cancer patients].
    Radzikowska E; Gaździk W; Rowińska-Zakrzewska E
    Pneumonol Alergol Pol; 1993; 61(9-10):496-502. PubMed ID: 8111326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipyrine metabolism in man: influence of age, alcohol, caffeine, and smoking.
    Vestal RE; Norris AH; Tobin JD; Cohen BH; Shock NW; Andres R
    Clin Pharmacol Ther; 1975 Oct; 18(4):425-32. PubMed ID: 1164824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired enzyme induction by rifampicin in the elderly.
    Twum-Barima Y; Finnigan T; Habash AI; Cape RD; Carruthers SG
    Br J Clin Pharmacol; 1984 May; 17(5):595-7. PubMed ID: 6733008
    [No Abstract]   [Full Text] [Related]  

  • 12. Gender as a factor in treating the elderly.
    Barry PP
    NIDA Res Monogr; 1986; 65():65-9. PubMed ID: 2874490
    [No Abstract]   [Full Text] [Related]  

  • 13. Reduced clearance of triazolam in old age: relation to antipyrine oxidizing capacity.
    Greenblatt DJ; Divoll M; Abernethy DR; Moschitto LJ; Smith RB; Shader RI
    Br J Clin Pharmacol; 1983 Mar; 15(3):303-9. PubMed ID: 6133545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipyrine half-life in hyperthyroidism.
    Obel AO; Ng'ang'a J; Gitau W
    East Afr Med J; 1981 Apr; 58(4):258-62. PubMed ID: 7261979
    [No Abstract]   [Full Text] [Related]  

  • 15. Enhanced antipyrine metabolism in cigarette smokers in Indian population.
    Uppal R; Garg SK; Sharma PR; Nair CR; Chaudhury RR
    Int J Clin Pharmacol Ther Toxicol; 1980 Jun; 18(6):269-71. PubMed ID: 7450928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cimetidine impairs the elimination of theophylline and antipyrine.
    Roberts RK; Grice J; Wood L; Petroff V; McGuffie C
    Gastroenterology; 1981 Jul; 81(1):19-21. PubMed ID: 7239117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interindividual differences in drug oxidation: clinical importance.
    Sjöqvist F; von Bahr C
    Drug Metab Dispos; 1973; 1(1):469-82. PubMed ID: 4149420
    [No Abstract]   [Full Text] [Related]  

  • 18. The use of benzodiazepines in the aged patient: clinical and pharmacological considerations.
    Dailly E; Bourin M
    Pak J Pharm Sci; 2008 Apr; 21(2):144-50. PubMed ID: 18390445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antipyrine half-life and drug elimination.
    Breckenridge A
    Clin Pharmacokinet; 1980; 5(3):201-3. PubMed ID: 7389234
    [No Abstract]   [Full Text] [Related]  

  • 20. A 5-year prospective assessment of the risk associated with individual benzodiazepines and doses in new elderly users.
    Tamblyn R; Abrahamowicz M; du Berger R; McLeod P; Bartlett G
    J Am Geriatr Soc; 2005 Feb; 53(2):233-41. PubMed ID: 15673346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.